Source: Business Wire

Press Release: Alitair : Global Bronchiectasis Pipeline Report 2016 - 12 Companies & Drug Profiles - Research and Markets

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Bronchiectasis - Pipeline Review, H1 2016" report to their offering. This report provides comprehensive information on the therapeutic development for Bronchiectasis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
James E. Hoyes's photo - Chairman & CEO of Alitair

Chairman & CEO

James E. Hoyes

CEO Approval Rating

90/100

Read more